The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Thresholds In Food Allergy evaluaTion And predictioN (TITAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06038019
Recruitment Status : Recruiting
First Posted : September 14, 2023
Last Update Posted : June 3, 2024
Sponsor:
Collaborators:
AAAAI Foundation
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Hamilton Health Sciences Corporation

Tracking Information
First Submitted Date August 18, 2023
First Posted Date September 14, 2023
Last Update Posted Date June 3, 2024
Actual Study Start Date November 1, 2023
Estimated Primary Completion Date November 1, 2050   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: September 7, 2023)
Eliciting dose thresholds to food challenge [ Time Frame: 1 year ]
Threshold are measured by controlled food challenge to incremental doses of allergen (g) and are adjudicated according to CoFAR v3.0 criteria
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures
 (submitted: September 7, 2023)
  • Food Allergy Quality of Life Questionnaire Child Form [ Time Frame: 1 year ]
    The number of items found in the child form questionnaire includes 30 items. Food allergy quality of life questionnaire is answered on a 7-point scale (0 to 6) with higher scores representing worse impairment.
  • Food Allergy Quality of Life Questionnaire Teen Form [ Time Frame: 1 year ]
    The number of items found in the Teen Form questionnaire includes 26 items. Food allergy quality of life questionnaire is answered on a 7-point scale (0 to 6) with higher scores representing worse impairment.
  • Food Allergy Quality of Life Questionnaire Adult Form [ Time Frame: 1 year ]
    The number of items found in the Adult Form questionnaire includes 35 items. Food allergy quality of life questionnaire is answered on a 7-point scale (0 to 6) with higher scores representing worse impairment.
  • Food Allergy Quality of Life Questionnaire Parent Form [ Time Frame: 1 year ]
    The number of items found in the Parent Form questionnaire includes 38 items. Food allergy quality of life questionnaire consists of 3 to 4 domains, each question is answered on a 7-point scale (0 to 6) with higher scores representing worse impairment.
  • Skin Prick Testing [ Time Frame: 1 year ]
    Measured by mean wheal size (mm)
  • Specific IgE [ Time Frame: 1 year ]
    Measured by ImmunoCap (kU/L)
  • Basophil Activation Test [ Time Frame: 1 year ]
    Measured by flow cytometry (cell frequency basophils and median fluorescence intensity)
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Thresholds In Food Allergy evaluaTion And predictioN
Official Title Thresholds In Food Allergy evaluaTion And predictioN, a Prospective, Multicentre Registry Study
Brief Summary Thresholds In food allergy evaluaTion And predictioN, a prospective, observational registry. The aim is to quantify food allergy thresholds in Canada and their clinical predictors.
Detailed Description Not Provided
Study Type Observational [Patient Registry]
Study Design Observational Model: Other
Time Perspective: Prospective
Target Follow-Up Duration 1 Day
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population All consecutive patients suspected or confirmed to be food allergic
Condition
  • Tree Nut Allergy
  • Food Allergy
Intervention Diagnostic Test: Oral food challenge
Patients will undergo oral food challenge with increasing amounts of food allergen
Study Groups/Cohorts Group 1
Patients with suspected or confirmed food allergy
Intervention: Diagnostic Test: Oral food challenge
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: September 7, 2023)
2000
Original Estimated Enrollment Same as current
Estimated Study Completion Date January 1, 2051
Estimated Primary Completion Date November 1, 2050   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  1. Suspicion or history of food allergy based on medical history, positive skin prick test, and/or serum food-specific IgE. A suggestive history is defined as typical clinical signs and/or symptoms (urticaria, angioedema, abdominal pain, vomiting, dyspnea, wheeze) within 60 minutes of the ingestion of a food.
  2. Ability to discontinue all antihistamines for 1 week before oral food challenge.

Exclusion Criteria:

  1. Previous desensitization treatment to a food allergen
  2. Allergies to any component of the oral challenge vehicle
  3. Unstable conditions including uncontrolled asthma or chronic urticaria
  4. Any clinically significant disease/chronic medical condition which may interfere with study evaluations.
Sex/Gender
Sexes Eligible for Study: All
Ages 3 Months to 65 Years   (Child, Adult, Older Adult)
Accepts Healthy Volunteers Yes
Contacts
Contact: Heather Le 905-525-9140 ext 75153 lehea@hhsc.ca
Listed Location Countries Canada
Removed Location Countries  
 
Administrative Information
NCT Number NCT06038019
Other Study ID Numbers NIF-20500
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Plan Description: Will consider on a case by case basis.
Current Responsible Party Hamilton Health Sciences Corporation
Original Responsible Party Same as current
Current Study Sponsor Hamilton Health Sciences Corporation
Original Study Sponsor Same as current
Collaborators
  • AAAAI Foundation
  • Canadian Institutes of Health Research (CIHR)
Investigators
Principal Investigator: Derek Chu, MD PhD FRCPC Hamilton Health Sciences & McMaster University
PRS Account Hamilton Health Sciences Corporation
Verification Date May 2024